Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Le Chevalier T, Brisgand D, Pujol JL, Douillard JY, Monnier A, Rivière A, Chomy P, Le Groumellec A, Ruffie P, Gottfried M, Gaspard MH, Chevreau C, Alberola V, Cigolari S, Besson F, Martinez A, Besenval M, Berthaud P, Tursz T. Le Chevalier T, et al. Among authors: gaspard mh. Bull Cancer. 1996 May;83(5):385-94. Bull Cancer. 1996. PMID: 8680091 Clinical Trial. French.
Renal tolerance of cisplatin in patients more than 80 years old.
Thyss A, Saudes L, Otto J, Creisson A, Gaspard MH, Dassonville O, Schneider M. Thyss A, et al. Among authors: gaspard mh. J Clin Oncol. 1994 Oct;12(10):2121-5. doi: 10.1200/JCO.1994.12.10.2121. J Clin Oncol. 1994. PMID: 7931482 Clinical Trial.
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies.
Gaspard MH, Maraninchi D, Stoppa AM, Gastaut JA, Michel G, Tubiana N, Blaise D, Novakovitch G, Rossi JF, Weiller PJ, et al. Gaspard MH, et al. Cancer Chemother Pharmacol. 1988;22(3):256-62. doi: 10.1007/BF00273421. Cancer Chemother Pharmacol. 1988. PMID: 3044633
Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001).
Mauriac L, Luporsi E, Cutuli B, Fourquet A, Garbay JR, Giard S, Spyratos F, Sigal-Zafrani B, Dilhuydy JM, Acharian V, Balu-Maestro C, Blanc-Vincent MP, Cohen-Solal C, De Lafontan B, Dilhuydy MH, Duquesne B, Gilles R, Lesur A, Shen N, Cany L, Dagousset I, Gaspard MH, Hoarau H, Hubert A, Monira MH, Perrié N, Romieu G; FNCLCC. Mauriac L, et al. Among authors: gaspard mh. Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S17-31. doi: 10.1038/sj.bjc.6601081. Br J Cancer. 2003. PMID: 12915900 Free PMC article. No abstract available.
47 results